WNK2 and heart disorder: A mass spectral peak of peptide in our study showed that peptide fragments such as mitogen-activated protein kinase (MAPK), kallikrein related peptidase (KLK), and tenascin-C (TN-C) appeared in the heart disease progression group (group B).